These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 27650675)

  • 1. Treating rheumatoid arthritis to target: physician and patient adherence issues in contemporary rheumatoid arthritis therapy.
    Wabe N; Wiese MD
    J Eval Clin Pract; 2017 Jun; 23(3):486-493. PubMed ID: 27650675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the acceptable level of physician compliance with a treat-to-target strategy in early rheumatoid arthritis.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf R; Hall C; Proudman SM; Wiese MD
    Int J Rheum Dis; 2017 May; 20(5):576-583. PubMed ID: 26692459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to a treat-to-target strategy in early rheumatoid arthritis: results of the DREAM remission induction cohort.
    Vermeer M; Kuper HH; Bernelot Moens HJ; Hoekstra M; Posthumus MD; van Riel PL; van de Laar MA
    Arthritis Res Ther; 2012 Nov; 14(6):R254. PubMed ID: 23176083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A patient-centered knowledge translation tool for treat-to-target strategy in rheumatoid arthritis: Patient and rheumatologist perspectives.
    Benham H; Chiu H; Tesiram J; Mehdi A; Landsberg P; Grosman S; Harrison A; Nash P; Thomas R; Langbecker D; Van Driel M
    Int J Rheum Dis; 2021 Mar; 24(3):355-363. PubMed ID: 33470051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of rheumatoid arthritis in clinical practice using treat-to-target strategy: Where do we stand in the multi-ethnic Malaysia population?
    Tan BE; Lim AL; Kan SL; Lim CH; Ng YF; Tng SLC; Hassin NS; Chandran L; Hamid NA; Lee YYL
    Rheumatol Int; 2017 Jun; 37(6):905-913. PubMed ID: 28389855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring patients with rheumatoid arthritis in routine care: experiences from a treat-to-target strategy using the DANBIO registry.
    Hetland ML; Jensen DV; Krogh NS
    Clin Exp Rheumatol; 2014; 32(5 Suppl 85):S-141-6. PubMed ID: 25365104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Adherence to a Treat-to-Target Protocol in Recent-Onset Rheumatoid Arthritis: Reasons for Compliance and Hesitation.
    Markusse IM; Dirven L; Han KH; Ronday HK; de Sonnaville PB; Kerstens PJ; Lems WF; Huizinga TW; Allaart CF
    Arthritis Care Res (Hoboken); 2016 Apr; 68(4):446-53. PubMed ID: 26239288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in the activity of rheumatoid arthritis as the consequence of treat-to-target strategy: eight-year data from 2009 to 2016.
    Xie W; Li J; Zhang X; Li G; Hao Y; Zhao J; Wang L; Sun X; Fan Y; Zhang Z
    Clin Exp Rheumatol; 2018; 36(5):820-828. PubMed ID: 29533754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treat-to-target in rheumatoid arthritis: Evaluating the patient perspective using the Patient Opinion Real-Time Anonymous Liaison system: The RA T2T PORTAL study.
    Benham H; Rutherford M; Kirby S; Stebbings S; White D; Sim D; Harrison A
    Int J Rheum Dis; 2019 May; 22(5):874-879. PubMed ID: 30793870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
    Caporali R; Conti F; Covelli M; Govoni M; Salaffi F; Ventriglia G; Montecucco C
    Clin Exp Rheumatol; 2014; 32(4):471-6. PubMed ID: 24960620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating rheumatoid arthritis to target: a Canadian patient survey.
    Haraoui B; Bensen W; Thorne C; Wade J; Deamude M; Prince J; Légaré J
    J Clin Rheumatol; 2014 Mar; 20(2):61-7. PubMed ID: 24561407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Adherence to Protocolized Targeted Intensifications of Disease-modifying Antirheumatic Drugs on Treatment Outcomes in Rheumatoid Arthritis: Results from an Australian Early Arthritis Cohort.
    Wabe NT; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee AT; Spargo LD; Metcalf RG; Hall C; Proudman SM; Wiese MD
    J Rheumatol; 2016 Sep; 43(9):1643-9. PubMed ID: 27422892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort.
    Sepriano A; Ramiro S; FitzGerald O; Østergaard M; Homik J; van der Heijde D; Elkayam O; Thorne JC; Larché MJ; Ferraccioli G; Backhaus M; Burmester GR; Boire G; Combe B; Schaeverbeke T; Saraux A; Dougados M; Rossini M; Govoni M; Sinigaglia L; Cantagrel A; Barnabe C; Bingham CO; Tak PP; van Schaardenburg D; Hammer HB; Paschke J; Dadashova R; Hutchings E; Landewé R; Maksymowych WP
    J Rheumatol; 2020 Jun; 47(6):809-819. PubMed ID: 31523049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obstacles to the implementation of the treat-to-target strategy for rheumatoid arthritis in clinical practice in Japan.
    Kaneko Y; Koike T; Oda H; Yamamoto K; Miyasaka N; Harigai M; Yamanaka H; Ishiguro N; Tanaka Y; Takeuchi T
    Mod Rheumatol; 2015 Jan; 25(1):43-9. PubMed ID: 24950169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three years.
    Wabe N; Sorich MJ; Wechalekar MD; Cleland LG; McWilliams L; Lee A; Spargo L; Metcalf RG; Hall C; Proudman SM; Wiese MD
    Arthritis Res Ther; 2015 Mar; 17(1):48. PubMed ID: 25889527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of physicians' adherence to treat-to-target strategy on outcomes in early rheumatoid arthritis in the NEO-RACo trial.
    Kuusalo L; Puolakka K; Kautiainen H; Blåfield H; Eklund KK; Ilva K; Kaipiainen-Seppänen O; Karjalainen A; Korpela M; Valleala H; Leirisalo-Repo M; Rantalaiho V;
    Scand J Rheumatol; 2015; 44(6):449-55. PubMed ID: 26324784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort.
    Vermeer M; Kuper HH; Moens HJ; Drossaers-Bakker KW; van der Bijl AE; van Riel PL; van de Laar MA
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1219-26. PubMed ID: 23436821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjustment in the clinical practice of treat-to-target guidelines for rheumatoid arthritis: Results of the ToARCan study.
    Naranjo A; Cáceres L; Hernández-Beriaín JÁ; Francisco F; Ojeda S; Talaverano S; Nóvoa-Medina J; Martín JA; Delgado E; Trujillo E; Álvarez F; Magdalena L; Rodríguez-Lozano C
    Reumatol Clin; 2016; 12(1):34-8. PubMed ID: 25869900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: comparison of two cohorts treated according to different treat-to-target protocols.
    Balduzzi S; Scirè CA; Sakellariou G; Benaglio F; Bugatti S; Montecucco C; Caporali R
    Clin Exp Rheumatol; 2017; 35(3):401-405. PubMed ID: 27974097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physician Adherence to Treat-to-Target and Practice Guidelines in Rheumatoid Arthritis.
    Batko B; Batko K; Krzanowski M; Żuber Z
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31500394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.